Cargando…

Implementation of multiplex PCR diagnostics for gastrointestinal pathogens linked to increase of notified Shiga toxin-producing Escherichia coli cases in Norway, 2007–2017

The aim of this study was to investigate implementation of multiplex PCR assays (broad screening PCR) on the distribution and characteristics of notified Shiga toxin-producing Escherichia coli (STEC) cases in Norway, 2007–2017. We described STEC cases notified to the Norwegian Surveillance System fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jenssen, Gaute Reier, Veneti, Lamprini, Lange, Heidi, Vold, Line, Naseer, Umaer, Brandal, Lin T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424946/ https://www.ncbi.nlm.nih.gov/pubmed/30680573 http://dx.doi.org/10.1007/s10096-019-03475-5

Ejemplares similares

Prevalence of genotypic antimicrobial resistance in clinical Shiga toxin-producing Escherichia coli in Norway, 2018 to 2020
por: Ramstad, Silje N., et al.
Publicado: (2021)

Large waterborne Campylobacter outbreak: use of multiple approaches to investigate contamination of the drinking water supply system, Norway, June 2019
por: Hyllestad, Susanne, et al.
Publicado: (2020)

The incidence and aetiology of acute kidney injury in children in Norway between 1999 and 2008
por: Jenssen, Gaute Reier, et al.
Publicado: (2014)

Shiga toxin-producing escherichia coli infections in Norway, 1992–2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome
por: Brandal, Lin T., et al.
Publicado: (2015)

Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999–2008 – a retrospective study of hospital records to assess the sensitivity of surveillance
por: Jenssen, Gaute Reier, et al.
Publicado: (2014)

Increasing incubation periods during a prolonged monophasic Salmonella Typhimurium outbreak with environmental contamination of a commercial kitchen at Oslo Airport, Norway, 2017
por: Siira, Lotta, et al.
Publicado: (2019)

Mapping of control measures to prevent secondary transmission of STEC infections in Europe during 2016 and revision of the national guidelines in Norway
por: Veneti, L., et al.
Publicado: (2019)

Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
por: Brandal, Lin T., et al.
Publicado: (2021)

Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992–2013
por: Naseer, U., et al.
Publicado: (2017)

Implications of screening and childcare exclusion policies for children with Shiga-toxin producing Escherichia coli infections: lessons learned from an outbreak in a daycare centre, Norway, 2012
por: MacDonald, Emily, et al.
Publicado: (2014)

Exotic dried fruits caused Salmonella Agbeni outbreak with severe clinical presentation, Norway, December 2018 to March 2019
por: Johansen, Tone Bjordal, et al.
Publicado: (2021)

Whole genome sequencing of Salmonella Chester reveals geographically distinct clusters, Norway, 2000 to 2016
por: Siira, Lotta, et al.
Publicado: (2019)

COVID-19 among immigrants in Norway, notified infections, related hospitalizations and associated mortality: A register-based study
por: Indseth, Thor, et al.
Publicado: (2021)

Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 – April 2021
por: Whittaker, Robert, et al.
Publicado: (2021)

Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999–2008
por: Jenssen, Gaute Reier, et al.
Publicado: (2016)

Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021
por: Veneti, Lamprini, et al.
Publicado: (2021)

Evaluation of the national surveillance of Legionnaires' disease in Norway, 2008-2017
por: Wolff, Cecilia, et al.
Publicado: (2019)

An outbreak of skin rash traced to a portable floating tank in Norway, May 2017
por: Hyllestad, Susanne, et al.
Publicado: (2019)

No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway
por: Veneti, Lamprini, et al.
Publicado: (2022)

Characterization of Shiga Toxin 2a Encoding Bacteriophages Isolated From High-Virulent O145:H25 Shiga Toxin-Producing Escherichia coli
por: Ramstad, Silje N., et al.
Publicado: (2021)

Compliance with water advisories after water outages in Norway
por: Hyllestad, Susanne, et al.
Publicado: (2019)

Shiga Toxin–producing Escherichia coli, New Mexico, USA, 2004–2007
por: Lathrop, Sarah, et al.
Publicado: (2009)

Comparative Genomics to Delineate Pathogenic Potential in Non-O157 Shiga Toxin-Producing Escherichia coli (STEC) from Patients with and without Haemolytic Uremic Syndrome (HUS) in Norway
por: Haugum, Kjersti, et al.
Publicado: (2014)

Seasonality of newly notified pulmonary tuberculosis in Japan, 2007–2015
por: Manabe, Toshie, et al.
Publicado: (2019)

Shiga Toxin-Producing Escherichia coli Outbreaks in the United States, 2010–2017
por: Tack, Danielle M., et al.
Publicado: (2021)

Shiga Toxin–Associated Hemolytic Uremic Syndrome in Adults, France, 2009–2017
por: Travert, Benoît, et al.
Publicado: (2021)

Epidemiological analysis of occupational dermatitis notified in Brazil in the period 2007 to 2012
por: Plombom, Gabriela Yumi, et al.
Publicado: (2016)

Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2022)

Incidence of notified Lyme borreliosis in Germany, 2013–2017
por: Enkelmann, Julia, et al.
Publicado: (2018)

Roles of Shiga Toxins in Immunopathology
por: Lee, Moo-Seung, et al.
Publicado: (2019)

Protection against Shiga Toxins
por: Kavaliauskiene, Simona, et al.
Publicado: (2017)

Shiga Toxins as Antitumor Tools
por: Robert, Aude, et al.
Publicado: (2021)

Evaluation of completeness and timeliness of data in the National Information System for Notifiable Diseases for spotted fever in the state of São Paulo, Brazil, 2007-2017
por: Xavier, Daniele Rosa, et al.
Publicado: (2023)

Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 – January 2022
por: Langlete, Petter, et al.
Publicado: (2023)

Phylogenetic analysis of Shiga toxin 1 and Shiga toxin 2 genes associated with disease outbreaks
por: Lee, James E, et al.
Publicado: (2007)

Purification and Characterization of Shiga Toxin 2f, an Immunologically Unrelated Subtype of Shiga Toxin 2
por: Skinner, Craig, et al.
Publicado: (2013)

Do the A Subunits Contribute to the Differences in the Toxicity of Shiga Toxin 1 and Shiga Toxin 2?
por: Basu, Debaleena, et al.
Publicado: (2015)

Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli
por: Baranzoni, Gian Marco, et al.
Publicado: (2016)

Contribution of cropland to the spread of Shiga toxin phages and the emergence of new Shiga toxin-producing strains
por: Quirós, Pablo, et al.
Publicado: (2017)

The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin E. coli Mediated HUS
por: Feitz, Wouter J. C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d3ka7ss6q6fnr4plr7e176nagl